Medium and supplement effects on the antimicrobial activity of quinupristin/dalfopristin tested by agar dilution and Etest methods

被引:7
作者
Jones, RN
机构
[1] Medical Microbiology Division, Department of Pathology, Univ. of Iowa College of Medicine, Iowa City, IA
[2] Medical Microbiology Division, Department of Pathology, 5232 RCP, Univ. of Iowa College of Medicine, Iowa City
关键词
D O I
10.1016/S0732-8893(96)00179-4
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Quinupristin/dalfopristin (also known as RP-59500 and Synercid), a streptogramin combination has been documented as active against a wide variety of Gram-positive species. Broad ranges of MIC results have been observed with some species using acceptable susceptibility testing methods. To address the contribution of testing medium and supplements to this disagreement, 15 medium or supplement alterations were studied in a reference agar dilution format and three variations of Mueller-Hinton agar mere used for Etest (AB Biodisk, Solna, Sweden). One-third of the agar dilution variations produced a consistent elevation (twofold) in the quinupristin/dalfopristin MIC. The greatest changes were secondary to additions of serum and blood, pH increases, and possibly charcoal. Similarly, the Etest MICs for quinupristin/dalfopristin were 0.5 to 2.5 log(2) dilutions higher with media supplemented with 5% sheep erythrocytes or when chocolated. Additional quinupristin/dalfopristin stability experiments in three agars indicate a two- to fourfold decline in potency over 21 days of storage at 2 to 5 degrees C. These variations in the streptogramin MIC results would be observed most frequently when testing fastidious species or in laboratories routinely testing all Gram-positive bacteria in or on blood-supplemented media. (C) 1996 Elsevier Science Inc.
引用
收藏
页码:99 / 102
页数:4
相关论文
共 9 条
[1]   FACTORS AFFECTING THE INVITRO ACTIVITY OF ROXITHROMYCIN [J].
ANDREWS, JM ;
ASHBY, JP ;
WISE, R .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1987, 20 :31-37
[2]   INVITRO ACTIVITY OF RP59500, AN INJECTABLE STREPTOGRAMIN ANTIBIOTIC, AGAINST VANCOMYCIN-RESISTANT GRAM-POSITIVE ORGANISMS [J].
COLLINS, LA ;
MALANOSKI, GJ ;
ELIOPOULOS, GM ;
WENNERSTEIN, CB ;
FERRARO, MJ ;
MOELLERING, RC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (03) :598-601
[3]   IN-VITRO ANTIMICROBIAL SUSCEPTIBILITY OF GLYCOPEPTIDE-RESISTANT ENTEROCOCCI [J].
FREEMAN, C ;
ROBINSON, A ;
COOPER, B ;
MAZENSSULLIVAN, M ;
QUINTILIANI, R ;
NIGHTINGALE, C .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1995, 21 (01) :47-50
[4]   IN-VITRO ACTIVITY OF RP-59500 (QUINUPRISTIN DALFOPRISTIN) AGAINST ANTIBIOTIC-RESISTANT STRAINS OF STREPTOCOCCUS-PNEUMONIAE AND ENTEROCOCCI [J].
JOHNSON, CC ;
SLAVOSKI, L ;
SCHWARTZ, M ;
MAY, P ;
PITSAKIS, PG ;
SHUR, AL ;
LEVISON, ME .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1995, 21 (03) :169-173
[5]  
JONES RN, 1995, MACROLIDES CHEM PHAR, P209
[6]  
National Committee for Clinical Laboratory Standards (NCCLS), 1993, METH DIL ANT SUSC TE, V3rd ed.
[7]   APPLICATION OF THE ETEST TO ANTIMICROBIAL SUSCEPTIBILITY TESTING OF LEGIONELLA SPP [J].
RHOMBERG, PR ;
BALE, MJ ;
JONES, RN .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1994, 19 (03) :175-178
[8]   EVALUATION AND CHARACTERIZATION OF MULTIRESISTANT ENTEROCOCCUS-FAECIUM FROM 12 US-MEDICAL-CENTERS [J].
SADER, HS ;
PFALLER, MA ;
TENOVER, FC ;
HOLLIS, RJ ;
JONES, RN .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (11) :2840-2842
[9]   ROXITHROMYCIN - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND CLINICAL EFFICACY [J].
YOUNG, RA ;
GONZALEZ, JP ;
SORKIN, EM .
DRUGS, 1989, 37 (01) :8-41